Gottlieb Outlines FDA Plans for Compounding Enforcement to Lawmakers

Drug Industry Daily
A A
In testimony before a House subcommittee Tuesday, FDA Commissioner Scott Gottlieb told lawmakers the FDA’s plans for regulating compounding pharmacies, including adapting GMP and oversight standards to a facility’s level of risk.

To View This Article:

Login

Subscribe To Drug Industry Daily